Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors.
Saved in:
| Title: | Association between higher glucose levels and reduced survival in patients with non-small cell lung cancer treated with immune checkpoint inhibitors. |
|---|---|
| Authors: | Osataphan S; Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, United States; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Awidi M; Lahey Hospital & Medical Center, Burlington, MA, United States; Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States., Jan YJ; Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, United States; Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States., Gunturu K; Lahey Hospital & Medical Center, Burlington, MA, United States; Hartford HealthCare Cancer Institute, Hartford, CT, United States., Sundararaman S; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Viray H; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Frankenberger E; Lahey Hospital & Medical Center, Burlington, MA, United States., Mariano M; Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, United States., O'Loughlin L; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Piper-Vallillo A; Lahey Hospital & Medical Center, Burlington, MA, United States., Stafford K; Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, United States; Denver Health & Hospital Authority, Denver, CO, United States., Kolnick A; Lahey Hospital & Medical Center, Burlington, MA, United States., Ghazalah H; Lahey Hospital & Medical Center, Burlington, MA, United States., Sehgal K; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States; Brigham and Women's Hospital, Boston, MA, United States., Patti ME; Joslin Diabetes Center, Harvard Medical School, Boston, MA, United States., Costa D; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States., Lam P; Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, United States., Rangachari D; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States. Electronic address: drangach@bidmc.harvard.edu. |
| Source: | Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Dec; Vol. 198, pp. 108023. Date of Electronic Publication: 2024 Nov 15. |
| Publication Type: | Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
